The awareness about mHealth services has significantly increased in the past few years that helps in enhancing the quality of life for individuals afflicted with lifestyle diseases.
APAC mHealth Industry Overview:
The awareness about mHealth services has significantly increased in the past few years that helps in enhancing the quality of life for individuals afflicted with lifestyle diseases. The rising incidence of diseases such as COPD, diabetes, hypertension, and obesity in the Asia Pacific region creates an imminent demand for high-tech platforms for the effective treatment and prevention of the syndromes.
Keeping in tab with the Center for Technology Innovation, India and China collectively tend to represent the extents with the biggest count of mobile devices. A steep surge in the usage of smart devices has enabled the population to get through the required healthcare-related services via wireless multimedia just in a jiffy. This, in turn, has fostered the incorporation of mHealth services in the Asia-Pacific region.
As per the National Institute of Health, India and China are again the two most populated countries, with a rough count of one-fifty million diabetic patients. And, this is the reason why health monitoring on a regular basis is highly important. Active initiatives by the majority of government bodies in the Asia-Pacific region and increasing adoption of smartphones in e tprovince have driven the market growth in more than one way. Currently, the market is witnessing a revival owing to rising disposable income of people, especially in countries such as Indonesia, India, and so on. According to Allied Market Research, the Asia-Pacific mHealth market is displayed a noteworthy CAGR from 2014 to 2020.
Request for Sample Report for More Insights @ https://www.alliedmarketresearch.com/request-sample/1173
Top Leading Players:
The key players profiled in this report include - Philips Healthcare, Omron HealthCare, Inc., Bayer Healthcare, LifeWatch AG, Masimo Corporation, Sanofi S.A., Boston Scientific Corporation, AT&T Inc. and Johnson & Johnson.
Covid-19 scenario-
Notably, the outbreak of the Covid-19 pandemic, in the first quarter of 2020, prompted digital transformation in the healthcare sector, with the usage of a number of avant-garde technologies. Several studies have been conducted on the use of telemedicine all through the pandemic and it’s revealed that telemedicine is truly considered as the future of healthcare in a lot of countries including India.
During the lockdown, telehealth happened to play a significant role in bridging the gap between common people, medical practitioners, and the overall health systems to be specific, permitting everyone, especially the symptomatic patients, to stay safe at home and connect with doctors via virtual platforms, therefore helping in the containment of the virus. These factors helped the Asia-Pacific mHealth market had a positive growth all through. This drift is also most likely to linger on post pandemic as well.